Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology

Abstract:
Audax Medical, Inc., a privately-held medical device company specializing in the development of osteobiologics, has entered into a comprehensive license agreement with Brown University, acquiring exclusive rights to a proprietary osteobiologic nanotechnology.

Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology

Littleton, MA | Posted on December 7th, 2010

The biomaterial, Arxis™, is being developed for use in multiple clinical applications for the regeneration of diseased bone, cartilage, and other soft tissues.

An additional research agreement has been completed with the Brown University School of Engineering and Department of Orthopedics to further support clinical development of the technology.

"Our partnership with Brown and the University's world-class scientific team is a significant milestone for Audax Medical," stated Mark A. Johanson, President and Chief Executive Officer. "The addition of this technology to the company's product portfolio greatly expands our growing regenerative osteobiologics and soft tissue platforms."

Under the terms of the agreement, Audax Medical has obtained exclusive license to a platform of intellectual property and technologies co-developed by Thomas Webster, Brown professor of engineering, addressing the treatment of degenerative bone and soft tissues.

"We are very excited to have partnered with such an experienced and accomplished team at Audax Medical," stated Katherine Gordon, Managing Director of the Brown University Technology Ventures Office. "The scientific and commercial expertise from both the Brown and Audax teams are impressive, offering a significant opportunity for both clinical and commercial success."

The Arxis™ biomaterial consists of organic nanomolecules which have the potential to meet an array of clinical needs. The implantable material can incorporate varying growth agents that allow its end characteristics to be customized for multiple clinical and regenerative indications throughout the musculoskeletal system.

More information about the science behind the technology, including pictures and video, can be found at today.brown.edu/articles/2010/11/audax.

####

About Audax Medical
Audax Medical, Inc. is a privately held medical device company located in Littleton, Massachusetts. The company offers innovative solutions for the treatment of degenerative bone and musculoskeletal tissue. The company's products go beyond simply stabilizing a clinical deficiency by promoting the growth of natural bone and tissue. With enhanced surgical based solutions and osteogenic biomaterial technologies, Audax offers a modern alternative to existing orthopedic therapies.

For more information, please click here

Contacts:
978.952.2522

Copyright © Audax Medical

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

University of Tehran Researchers Invent Non-Enzyme Sensor to Detect Blood Sugar April 23rd, 2014

Gold nanoparticles help target, quantify breast cancer gene segments in a living cell April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Possible Futures

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014

Local girl does good March 22nd, 2014

Surface Characteristics Influence Cellular Growth on Semiconductor Material March 12th, 2014

The "Tipping Point" February 12th, 2014

Nanomedicine

University of Tehran Researchers Invent Non-Enzyme Sensor to Detect Blood Sugar April 23rd, 2014

Gold nanoparticles help target, quantify breast cancer gene segments in a living cell April 23rd, 2014

QuantuMDx announce prototype handheld lab for 15 minute malaria diagnosis and drug resistance testing April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

Announcements

Characterizing inkjet inks: Malvern Instruments presents new rheological research April 23rd, 2014

NanoSafe, Inc. announces the addition of the Labconco Protector® Glove Box to its NanoSafe Tested™ registry April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Patents/IP/Tech Transfer/Licensing

Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014

Nanoparticles cause cancer cells to self-destruct April 3rd, 2014

A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014

Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014

Nanobiotechnology

University of Tehran Researchers Invent Non-Enzyme Sensor to Detect Blood Sugar April 23rd, 2014

Gold nanoparticles help target, quantify breast cancer gene segments in a living cell April 23rd, 2014

Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014

Cloaked DNA nanodevices survive pilot mission: Successful foray opens door to virus-like DNA nanodevices that could diagnose diseased tissues and manufacture drugs to treat them April 22nd, 2014

Alliances/Partnerships/Distributorships

Economics = MC2 -- A portrait of the modern physics startup: Successful companies founded by physicists often break the Silicon Valley model, according to new American Institute of Physics report April 23rd, 2014

Global leader in solar cell manufacturing eyes New York for major expansion outside of Japan: CNSE and Solar Frontier Explore $700 Million Investment, Job Creation in New York State April 22nd, 2014

ASM International Repositions Brand and Introduces New Logo; Looks to Future of Materials Science Innovation: New logo celebrates organization’s history and provides fresh elements for future growth April 21st, 2014

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014

Acquisitions/Mergers/Splits

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

Applied Nanotech Holdings, Inc. (OTCQB: APNT) and Nanofilm, Ltd. Sign Merger Agreement March 14th, 2014

Harris & Harris Group Notes Molecular Imprints' Semiconductor Business To Be Acquired By Canon February 14th, 2014

FEI Buys Digital Rock Solutions Provider and microCT Product: Lithicon’s Solutions Will Expand FEI’s Oil & Gas Industry Offerings February 5th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE